Knock down of APE1 suppressed gastric cancer metastasis via improving immune disorders caused by myeloid-derived suppressor cells

References

• Tsutsumi C, Ohuchida K, Katayama N, et al. Tumor-infiltrating monocytic myeloid-derived suppressor cells contribute to the development of an immunosuppressive tumor microenvironment in gastric cancer. Gastric Cancer. 2024;27(2):248–262. doi: 10.1007/s10120-023-01456-4
   PubMed Web of Science ®Google Scholar
• Kao KD, Grasberger H, El-Zaatari M. The Cxcr2(+) subset of the S100a8(+) gastric granylocytic myeloid-derived suppressor cell population (G-MDSC) regulates gastric pathology. Front Immunol. 2023;14:1147695. doi: 10.3389/fimmu.2023.1147695
   PubMed Web of Science ®Google Scholar
• Chen Y, Liu J, Chen Y, et al. Jianpi Yangzheng Xiaozheng decoction alleviates gastric cancer progression via suppressing exosomal PD-L1. Front Pharmacol. 2023;14:1159829. doi: 10.3389/fphar.2023.1159829
   PubMed Web of Science ®Google Scholar
• Liu Y, Wei D, Deguchi Y, et al. PPARδ dysregulation of CCL20/CCR6 axis promotes gastric adenocarcinoma carcinogenesis by remodeling gastric tumor microenvironment. Gastric Cancer. 2023;26(6):904–917. doi: 10.1007/s10120-023-01418-w
   PubMed Web of Science ®Google Scholar
• Tang Y, Zhou C, Li Q, et al. Targeting depletion of myeloid-derived suppressor cells potentiates PD-L1 blockade efficacy in gastric and colon cancers. Oncoimmunology. 2022;11(1):2131084. doi: 10.1080/2162402X.2022.2131084
   PubMed Web of Science ®Google Scholar
• Ding L, Chakrabarti J, Sheriff S, et al. Toll-like receptor 9 pathway mediates Schlafen(+)-MDSC Polarization During Helicobacter-induced Gastric Metaplasias. Gastroenterology. 2022;163(2):411–25 e4. doi: 10.1053/j.gastro.2022.04.031
   PubMed Web of Science ®Google Scholar
• Zhou X, Fang D, Liu H, et al. PMN-MDSCs accumulation induced by CXCL1 promotes CD8(+) T cells exhaustion in gastric cancer. Cancer Lett. 2022;532:215598. doi: 10.1016/j.canlet.2022.215598
   PubMed Web of Science ®Google Scholar
• Kodach LL, Peppelenbosch MP. Targeting the myeloid-derived suppressor cell compartment for inducing responsiveness to immune checkpoint blockade is best limited to specific subtypes of gastric cancers. Gastroenterology. 2021;161(2):727. doi: 10.1053/j.gastro.2021.03.047
   PubMed Web of Science ®Google Scholar
• Kim HD, Ryu MH, Yoon S, et al. Clinical implications of neutrophil-to-lymphocyte ratio and MDSC kinetics in gastric cancer patients treated with ramucirumab plus paclitaxel. Chin J Cancer Res. 2020;32(4):621–630. doi: 10.21147/j.issn.1000-9604.2020.05.07
   PubMedGoogle Scholar
• Zhang Y, Sun M, Xie J, et al. Dual-signal amplification strategy based on Catalytic Hairpin Assembly and APE1-assisted amplification for high-contrast miRNA imaging in living cells. Anal Chem. 2024;96(2):910–916. doi: 10.1021/acs.analchem.3c05013
   PubMed Web of Science ®Google Scholar
• Siqueira PB, de Sousa Rodrigues MM, de Amorim ISS, et al. The APE1/REF-1 and the hallmarks of cancer. Mol Biol Rep. 2024;51(1):47. doi: 10.1007/s11033-023-08946-9
   PubMed Web of Science ®Google Scholar
• Gautam A, Fawcett H, Burdova K, et al. APE1-dependent base excision repair of DNA photodimers in human cells. Mol Cell. 2023;83(20):3669–78 e7. doi: 10.1016/j.molcel.2023.09.013
   PubMed Web of Science ®Google Scholar
• Korbecki J, Bosiacki M, Barczak K, et al. The clinical significance and role of CXCL1 chemokine in gastrointestinal cancers. Cells. 2023;12(10):12. doi: 10.3390/cells12101406
   Web of Science ®Google Scholar
• Liu X, Yan C, Yang A, et al. Efficacy of anti-programmed cell death protein 1 monoclonal antibody combined with bevacizumab and/or Pseudomonas aeruginosa injection in transplanted tumor of mouse forestomach carcinoma cell gastric cancer in mice and its mechanism in regulating tumor immune microenvironment. Clin Exp Immunol. 2023;213(3):328–338. doi: 10.1093/cei/uxad069
   PubMed Web of Science ®Google Scholar
• Ding L, Sheriff S, Sontz RA, et al. Schlafen4(+)-MDSC in Helicobacter-induced gastric metaplasia reveals role for GTPases. Front Immunol. 2023;14:1139391. doi: 10.3389/fimmu.2023.1139391
   PubMed Web of Science ®Google Scholar
• Chen Y, Chen Y, Tan S, et al. Visual analysis of global research on immunotherapy for gastric cancer: a literature mining from 2012 to 2022. Human Vaccines Immunother. 2023;19(1):2186684. doi: 10.1080/21645515.2023.2186684
   PubMed Web of Science ®Google Scholar
• Kim W, Chu TH, Nienhuser H, et al. PD-1 signaling promotes tumor-infiltrating myeloid-derived suppressor cells and gastric tumorigenesis in mice. Gastroenterology. 2021;160(3):781–796. doi: 10.1053/j.gastro.2020.10.036
   PubMed Web of Science ®Google Scholar
• Liu M, Zhang Y, Chen L, et al. Myeloid-derived suppressor cells in gastroenteropancreatic neuroendocrine neoplasms. Endocrine. 2021;71(1):242–252. doi: 10.1007/s12020-020-02467-2
   PubMed Web of Science ®Google Scholar
• Yamaguchi T, Fushida S, Kinoshita J, et al. Extravasated platelet aggregation contributes to tumor progression via the accumulation of myeloid‑derived suppressor cells in gastric cancer with peritoneal metastasis. Oncol Lett. 2020;20(2):1879–1887. doi: 10.3892/ol.2020.11722
   PubMed Web of Science ®Google Scholar
• Tavukcuoglu E, Horzum U, Yanik H, et al. Human splenic polymorphonuclear myeloid-derived suppressor cells (PMN-MDSC) are strategically located immune regulatory cells in cancer. Eur J Immunol. 2020;50(12):2067–2074. doi: 10.1002/eji.202048666
   PubMed Web of Science ®Google Scholar
• Fabian KP, Padget MR, Donahue RN, et al. PD-L1 targeting high-affinity NK (t-haNK) cells induce direct antitumor effects and target suppressive MDSC populations. J Immunother Cancer. 2020;8(1):e000450. doi: 10.1136/jitc-2019-000450
   PubMed Web of Science ®Google Scholar
• Corzo CA, Condamine T, Lu L, et al. HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment. J Exp Med. 2010;207(11):2439–2453. doi: 10.1084/jem.20100587
   PubMed Web of Science ®Google Scholar
• Condamine T, Kumar V, Ramachandran IR, et al. ER stress regulates myeloid-derived suppressor cell fate through TRAIL-R–mediated apoptosis. J Clin Invest. 2014;124(6):2626–2639. doi: 10.1172/JCI74056
   PubMed Web of Science ®Google Scholar
• Condamine T, Gabrilovich DI. Can the suppressive activity of myeloid-derived suppressor cells Be “Chop”ped? Immunity. 2014;41(3):341–342. doi: 10.1016/j.immuni.2014.08.016
   PubMed Web of Science ®Google Scholar
• Lu H, Cao LL, Ballout F, et al. Reflux conditions induce E-cadherin cleavage and EMT via APE1 redox function in oesophageal adenocarcinoma. Gut. 2023;73(1):47–62. doi: 10.1136/gutjnl-2023-329455
   PubMed Web of Science ®Google Scholar
• Tao J, Zhang H, Weinfeld M, et al. Development of a DNAzyme walker for the detection of APE1 in living cancer cells. Anal Chem. 2023;95(40):14990–14997. doi: 10.1021/acs.analchem.3c02574
   PubMed Web of Science ®Google Scholar